This journal activity provides practitioners with the knowledge needed to understand the potential for use of data standardization via the O3 to facilitate creation of large real-world datasets.

This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.

This journal activity provides practitioners with the fundamental understanding needed to care for transfeminine patients with cancer, including overview of gender affirming surgeries, nodal coverage and radiation techniques, as well as  expert recommendations for communication with transgendered

Using a case-based approach, this activity discusses challenging scenarios that are encountered in the management of women with uterine cancer.

This session highlights five of the most clinically relevant abstracts within the Gastrointestinal track of the 2022 ASTRO Annual Meeting Scientific Program.

This activity includes a panel of experts from breast radiation oncology, surgical oncology, medical oncology, and pathology to discuss the following rare histologies/breast cancer presentations: 1) Pleomorphic LCIS- diagnosis and differential (path) appropriate margin width (surgeon), role of ad

This journal activity provides practitioners with the knowledge needed to treat oligometastatic cancer.

This journal activity provides practitioners with the knowledge needed to appropriate counsel and educate patients requiring chemoradiotherapy for esophageal cancer and provide practitioners with the knowledge regarding common late effects of treatment in this patient population.

This activity reviews the various oligometastatic states, existing and upcoming data supporting radiation in appropriately selected patients, intersection of radiation with systemic therapy, and practical applications of radiation treatment delivery with a focus on stereotactic ablative radiation

To access the Live event on October 19, 2023 at 2 p.m. Eastern time - Click on take course and then navigate past the homework to the Join the Webinar link.

This webinar will cover the clinical evidence and rationale for focal dose escalation to the MRI-defined GTV in prostate cancer.